MedTech Leader Remidio invests in UK’s Occuity

Strategic partnership to advance early disease detection with cutting-edge optical technology In a move set to redefine non-invasive disease detection, Remidio, a global leader in AI-powered ophthalmic solutions, has strategically invested in Occuity, a pioneering UK-based developer of handheld, optical screening and monitoring devices that are non-contact and require no consumables. The inve